Related Experiment Videos
Acceptor substrate-based selective inhibition of galactosyltransferases
S J Chung1, S Takayama, C H Wong
1Department of Chemistry, Scripps Research Institute, La Jolla, CA 92037, USA.
Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
Summary
Researchers discovered potent, selective inhibitors for key enzymes (alpha-1,3- and beta-1,4-galactosyltransferases). Aromatic group modification of enzyme acceptors yielded the first small, uncharged molecules for a new glycosyltransferase inhibitor strategy.
Area of Science:
- Biochemistry
- Enzymology
- Medicinal Chemistry
Background:
- Glycosyltransferases are crucial enzymes in synthesizing complex carbohydrates.
- Selective inhibition of specific glycosyltransferases is challenging but therapeutically important.
- Existing inhibitors often lack potency or selectivity for alpha-1,3- and beta-1,4-galactosyltransferases.
Purpose of the Study:
- To discover and characterize novel small molecule inhibitors targeting alpha-1,3- and beta-1,4-galactosyltransferases.
- To develop a new strategy for creating selective glycosyltransferase inhibitors.
Main Methods:
- Synthesis of glycosyl acceptor analogs with modifications at the aglycon position.
- Enzyme inhibition assays to determine potency and selectivity against target galactosyltransferases.
- Structure-activity relationship analysis to identify key structural features for inhibition.
Main Results:
- Discovery of potent and selective inhibitors based on glycosyl acceptor analogs.
- Demonstration that incorporating an aromatic group at the aglycon position significantly enhances inhibition.
- Identification of these analogs as the first small, uncharged molecules exhibiting potent and selective inhibition of both alpha-1,3- and beta-1,4-galactosyltransferases.
Conclusions:
- Glycosyl acceptor analogs with specific aromatic modifications represent a promising class of selective glycosyltransferase inhibitors.
- This discovery offers a novel strategy for developing targeted therapeutics for diseases involving aberrant glycosylation.
- The identified inhibitors provide valuable tools for further biochemical and biological studies of galactosyltransferase function.